Biopharma Group's research and development and analytical services constitute the foundation of innovation in the pharma and biotech fields.
Our team of experts combine cutting-edge techniques and state-of-the-art instruments to unravel complex challenges and drive product development. With a focus on Quality by Design (QbD) and Design of Experiment (DoE) principles, we aim to optimise both dried and liquid formulations in an efficient and cost-effective manner.
5 reasons to choose Biopharma Group as your CDMO partner
- Expertise
- Flexibility
- Fast turnaround
- Competitive costs
- Quality control & compliance
Biopharma Group: How we achieve results
- DOE (Design of Experiments)
- QbD(Quality by Design)
- Low Bioburden and GMP facilities
- ISO:9001 and ISO:13485 accreditations
- Cat D labs for sensitive & HPAPI sample processing
Biopharma Group: Why, and how it helps customers?
- Elimination of the cold chain
- Extension of product stability
- Efficient storage and transportation
- Increased productivity
- Optimised operations
- Improved batch yield
- Simplified scale-up and process transfer
- Ownership of intellectual property rights
Download a copy of our "Pharmaceutical Services & Solutions" overview brochure, click here
More Information
Proof of concept studies:
At Biopharma Group, one of our popular R&D services during the initial phases of product development, is proof-of-concept and feasibility studies. . Biopharma Group has the capability to conduct early-stage development and process audits to determine the most efficient method to take your product all the way to production; whether it be non-aseptic or, for the likes of phase 1 or 2 clinical trials, GMP production and assist in the first steps to establishing the reliability, integrity and viability of your sample. Formulation and lyo cycle development:
Here at Biopharma Group, we are proud to offer a range of formulation and lyo consultancy services. We can provide a range of specialist pharma R&D solutions designed to suit your needs – from lyo-cycle development and process reviews to production, packing and shipping.Each of our research and development or analysis services are expertly managed by our team of scientists - who are on hand to support you and ensure that you reach your goals in a timely and cost-effective manner.
Material characterisation:
Material characterisation is an important process where the chemical, microstructure and physical properties of a material are probed, measured and determined using a range of analytical methods, techniques and tools.At Biopharma Group we aim to perform material characterisation processes that can enhance and inform your future formulation development – providing the correct next steps that are founded on extensive research and development processes.
Design space, tech transfer and scale up:
Biopharma Group scientists are able to work on projects of different sizes and scopes. From larger scale formulation projects to smaller trouble-shooting processes, we have the facilities to help scale-up your project in a resourceful way.Ad hoc consultancy:
At Biopharma Group, we are proud to offer a range of ad hoc consultancy services. Our in-house science team has a wealth of expertise and is on hand to provide recommendations and improvements regarding your formulations, processes and next steps. We aim to provide useful insight into your existing procedures to determine where you can make improvements and how you can go about changing your methodology.Specialist analytical services – FDM, DVS, SEM, XRD:
600ppi.jpg)
In addition to our freeze drying and standard R&D services, we also have specialist analyitical tools that help to ensure that your product is developed as efficiently as possible for the long-term. these additional analyses include:"FDM" means Freeze Drying Microscopy. This analysis is used to to determine the critical events of a freeze-drying cycle such as collapse and annealing that dictate the primary and secondary drying steps of a lyo cycle.
"DVS" stands for Dynamic Vapour Sorption - A gravimetric technique used as a post-lyo analysis to measure the mass of a sample as it changes in response to alterations in temperature or humidity.
"SEM" or Scanning Electron Microscopy, is an analysis process that scans a sample with an electron beam to produce a magnified image for analysis. The method is used in microanalysis and failure analysis of solid inorganic materials.
X-Ray diffraction analysis, aka, XRD, is a non-destructive technique that provides detailed information about the crystallographic structure, chemical composition, and physical properties of a material.
Ask the experts
Biopharma Group specialises in contract R&D for dried product and liquid formulations of pharmaceuticals, diagnostics and biological materials. With specialist in-house facilities and scientists, we can conduct an extensive range of services from proof-of-concept studies, through to formulation and cycle development, pre-and post-process analysis to non-GMP production for diagnostics.
Soon, our GMP freeze drying facility will be available to meet the requirements for small batch, first-in-human clinical trials production too. This expertise is guided by the in-depth knowledge of freeze drying, which has continually evolved for over more than 30 years – positioning Biopharma Group as a worldwide hub for drying process related projects, and most recently for improving efficiencies in lyobead processing.
Speak directly to a member of our team to better understand how our services could make us the perfect CDMO partner.
